Projects
Chosen filters:
Chosen filters:
In vitro effect of diabetes farmaca on beta cell proliferation
Unravelling Data for Rapid Evidence-Based Response to COVID-19 Institute of Tropical Medicine
Department of Public Health, Management, University of Sarajevo, Associacao pro Ensino Superior em Novo Hamburgo, University of Antioquia {Universidad de Antioquia}, University of South Florida, Korea University, Azienda ULSS 6 Euganea, St Mary's University, Twickenham, Baskent University, Institute for Anthropological Research, Croatian National Institute of Public Health, Sciensano, Brussels, Belgium, Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar (Verona), Italy., University of South-Eastern Norway, University of Thessaly, Instituto Investigacion Sanitaria Fundacion Jimenez Diaz, Fundacion para la Investigacion Biomedical del Hospital Universitario La Princesa, Instituto Politecnico de Coimbra, Trnavska Univerzita V Trnave, Universidade Catolica Portuguesa, Luxembourg Institute of Health, Universitatea de Medicina si Farmacie Grigore T Popa Din Iasi, Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj-Napoca, University College Cork - National University of Ireland, Cork, Technological University Dublin, Universidade do Porto, University of Navarra, Polytechnic University of Madrid-UPM, Fundacion Investigation HM Hospitales, Non-communicable Diseases, Institute of Tropical Medicine
unCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19
patients by health systems across Europe and internationally. These real-world data allow for studies into patient’s
characteristics, risk factors, safety and effectiveness of treatments and potential strategies against COVID-19 in real
settings, and complement findings from efficacy/safety clinical trials ...
patients by health systems across Europe and internationally. These real-world data allow for studies into patient’s
characteristics, risk factors, safety and effectiveness of treatments and potential strategies against COVID-19 in real
settings, and complement findings from efficacy/safety clinical trials ...
Targeting Circadian Clock Dysfunction in Alzheimer’s Disease Ghent University
Department of Marketing, Innovation and Organisation, University of Würzburg, University of Verona, NOSTRUM BIODISCOVERY SL, Tel Aviv University, IMDEA Nanoscience, Foundation for Research and Technology Hellas, BIOFABICS LDA, University of Bologna, University of Santiago de Compostela, Faculdade de Farmácia da Universidade de Lisboagrid.9983.b, Mario Negri Institute for Pharmacological Research
the PhD project fits within an ITN project of the European commission, in which 16 researchers conduct research into Alzheimer's disease, and more specifically, the role of the circadian clock. Within this PhD project, the commercialization of newly developed tools and cures will be studied.
GOGO: Goudsbloem, een gouden kans! Province of Flemish Brabant
Integrating Logistics Processes in Practice Enterprises (LOGIPRO) HOWEST
HOWEST, Researchgroup Business management, Institut El Calamot (beroepsonderwijs), Sint-Jozef Sint-Pieter school (Beroepsonderwijs), Europen-PEN International e.V., FUNDACIO PRIVADA INFORM-INSTITUT PER A LA FORMACIO DE JOVES VERS L'ADMINISTRACIO D'EMPRESES, Connectief vzw
The logistics sector requires highly qualified profiles. These profiles do not yet exist, which means companies have to train new employees first, consuming a lot of time and money. This Erasmus+ project aims to develop a learning program that prepares European students for a logistics education in higher education or for a job within a logistics company. To achieve this, a virtual company is established following the PE method. Each PE engages ...
Translating therapeutic drug monitoring of biopharmaceuticals into individualised care of inflammatory bowel disease patients through pharmacometric modelling en farmaco-economic evaluation. KU Leuven
Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD). Approximately 2.2 million patients suffer from these incurable disabling diseases in Europe. State-of-the-art anti-tumour necrosis factor (TNF) alpha treatment (e.g. infliximab, adalimumab) is increasingly used throughout the disease course to induce and maintain clinical remission in IBD patients. Notwithstanding these drugs are very efficacious; nearly 40% ...
Protection of endothelia for prevention of diabetic cardiomyopathy. University of Antwerp
The central hypothesis of this project is that disturbances of endothelium-cardiomyocyte cross-talk contribute to the patrhogenesis of diabetes-induced cardiomyopathy. The aims are: 1. To test whether treatment with an endothelium-protective farmacon NEBIVOLOL protects against development of diabetic CMP (and against vascular endothelial dysfunction) 2. To test whether a disturbed paracrine endothelial regulation of cardiac function through ...